View Agent
| Agent Info | |
| Agent: | AMG102 |
| Synonyms: | rilotumumab |
| Drug Status For Certain Diseases: | Discontinued inphase 2(Grade IV malignant glioma;Glioblastoma multiforme) |
| Classification: | a fully human monoclonal antibody against hepatocyte growth factor/scatter factor (HGF/SF) |
| Target: | hepatocyte growth factor/scatter factor (HGF/SF) |
| KEGG Pathway: | Renal cell carcinoma Pathways in cancer Malaria Focal adhesion Cytokine-cytokine receptor interaction Melanoma Proteoglycans in cancer Rap1 signaling pathway PI3K-Akt signaling pathway Ras signaling pathway |
| Wiki Pathway: | Prostate Cancer Interleukin-7 signaling NRF2 pathway Nuclear Receptors Meta-Pathway Differentiation Pathway Focal Adhesion Extracellular vesicle-mediated signaling in recipient cells Signaling of Hepatocyte Growth Factor Receptor |